US Patent 10301258 Benzende sulfonamide derivatives as HIV integrase inhibitors
Patent 10301258 was granted and assigned to Howard University on May, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+296 characters)
Article
Patent abstract
Methods for treating retroviral infection or inhibiting HIV integrase in target cells or in a patient involve administering to target cells or to a patient in need of treatment an effective amount of at least one having a disulfonamide scaffold which is represented by the formula:
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Xiang Simon Wang0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
103012580
Date of Patent
May 28, 2019
0Patent Application Number
151142890
Date Filed
February 26, 2015
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 26 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10301258 Benzende sulfonamide derivatives as HIV integrase inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10301258
Date of patent
May 28, 2019
Patent application number
15114289
Date Filed
February 26, 2015
Patent primary examiner
Find more entities like US Patent 10301258 Benzende sulfonamide derivatives as HIV integrase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.